Clinical Trials List
2020-08-07 - 2022-07-01
Phase II
Recruiting4
ICD-10J12.2
Parainfluenza virus pneumonia
ICD-9480.2
Pneumonia due to parainfluenza virus
A Phase IIb Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Severe Influenza Infection
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
Ansun Biopharma, Inc.
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Nan-Yao Lee Division of General Internal Medicine
- 薛伶珊 Division of General Internal Medicine
- Jiun-Ling Wang Division of General Internal Medicine
- Po-Lin Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen Chia-Hung Division of Thoracic Medicine
- Wen-Chien Cheng Division of Thoracic Medicine
- Zhi-Yu Chen Division of Thoracic Medicine
- 陳韋成 Division of Thoracic Medicine
- Bing-Ru Wu Division of Thoracic Medicine
- 廖偉志 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 錢穎群 Division of General Internal Medicine
- CHUN-TA HUANG Division of General Internal Medicine
- 郭律成 Division of General Internal Medicine
- 許甯傑 Division of General Internal Medicine
- 阮聖元 Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- Ping-Hung Kuo Division of General Internal Medicine
- 陳永瑄 Division of General Internal Medicine
- 李佩玲 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
280 participants
